B12 Injections Weight Loss Before and After: What the Evidence Actually Shows

The myth: B12 injections are a shortcut to the results you're seeing online

It's genuinely understandable to arrive at this question hopeful. The before-and-after images are compelling, and 'weight-loss injection' has become an umbrella term online for anything delivered with a needle. The problem is that the phrase is doing a lot of heavy lifting.

Vitamin B12 (cobalamin) is involved in red blood cell production, nerve function and DNA synthesis. People whose bodies struggle to absorb it (commonly because of pernicious anaemia, certain medications or post-bariatric-surgery changes) are prescribed hydroxocobalamin or cyanocobalamin injections. Those injections correct a genuine deficiency. When fatigue and weakness lift, some people do become more active, and some people do lose a little weight as a downstream effect of feeling better. That secondary effect is not the same thing as a weight-loss medicine.

If you're researching what B12 injections can and cannot do for weight loss, NHS guidance on B12 treatment does not list weight reduction as an effect or indication. No randomised controlled trial has shown that B12 injections reduce body weight in adults who already have adequate B12 levels. The before-and-after transformations attributed to 'B12 shots' in wellness clinics almost always involve concurrent dietary changes, other supplements, or (in some cases) undisclosed medicines. The B12 is window dressing.

If correcting a deficiency sounds relevant to you, speak to your GP. If you're looking at those results and wanting the actual medicine behind them, read on.

What the results people are really after come from

The injections producing the kind of body-weight changes that fill before-and-after galleries are GLP-1 receptor agonist medicines — specifically tirzepatide (Mounjaro) and semaglutide (Wegovy). Both are licensed in the UK for weight management in eligible adults, and both work through an entirely different mechanism from a vitamin supplement.

Tirzepatide activates two gut-hormone receptors simultaneously: GIP and GLP-1. This slows gastric emptying, reduces appetite and changes how the brain processes hunger signals. In SURMOUNT-1, a 72-week clinical trial involving 2,539 adults with obesity, participants on the highest dose lost around 20–21% of body weight on average, a figure reported in the New England Journal of Medicine. Wegovy (semaglutide) works on the GLP-1 pathway alone and produced around 15% average weight loss over 68 weeks in its pivotal trial.

Those are the numbers behind the results. They come from a clinical programme, a licensed medicine, a real prescription, and medical oversight, not from a vitamin drip. If you want to understand what weight loss injections results before and after look like across different doses and timelines, the context matters as much as the headline figure.

Both medicines carry a Black Triangle (▼) designation from the MHRA, meaning they are subject to additional monitoring. They are prescription-only medicines, a prescriber assesses whether they are clinically appropriate for you before any treatment begins. There are no shortcuts around that step, and responsible providers don't offer them.

How to read before-and-after content without being misled

A few things worth knowing before you take any before-and-after image at face value. First, UK law prohibits the advertising of prescription-only medicines to the public, which means any dramatic before-and-after campaign attributed to a named POM is likely in breach of MHRA guidance. Credible clinical services don't run those campaigns.

Second, the MHRA has warned publicly about counterfeit and illegally sold weight-loss pens, fake products have been seized in large quantities across the UK, some containing dangerous substances. Anything sold without clinical assessment, or from a seller you cannot verify on the GPhC pharmacy register, is a serious risk. You can report suspect sellers at the MHRA's Yellow Card site.

Third, the word 'injection' in a before-and-after headline tells you almost nothing. Ask what the injection contained, whether it was a licensed medicine, whether the person had a prescription, and whether a qualified prescriber was involved. Those questions filter out most of what's in those galleries very quickly. If you want to see what results from the licensed UK medicines look like in practice, browsing weight loss injections before and after pictures from regulated services is a more grounded starting point, and if you're specifically researching semaglutide outcomes, Saxenda weight loss injections before and after content can help illustrate what that medicine has produced in real-world use.

What an eligibility check for a licensed weight-loss injection actually involves

Mounjaro and Wegovy are licensed for adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition, such as high blood pressure, high cholesterol, prediabetes or obstructive sleep apnoea. Lower thresholds apply for some ethnic backgrounds under UK clinical guidance. BMI alone is never the whole picture; the prescriber looks at your medical history, current medicines and individual circumstances.

At nume, that assessment is done by a GPhC-registered Independent Prescriber, not software. Consultations are free, and if treatment is clinically appropriate, it can be dispensed the same day from our GPhC-registered pharmacy (registration number 9012878, verifiable at pharmacyregulation.org). If you're weighing up what the process looks like (and what it costs) our treatment page sets it out plainly.

NHS guidance on tirzepatide covers who it is for, how it works and what to expect. That's a reliable place to cross-reference anything you read elsewhere. Vitamin B12 may be many things. A weight-loss injection is not one of them.